Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

230
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
230
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

365
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
365
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

583
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
583
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

608
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
608
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

2.1K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning to optimize the diagnostic performance of natriuretic peptides for acute heart failure across age groups.

ESC heart failure·2026
Same author

COVID-19 Vaccination Uptake and Myocarditis and/or Pericarditis Complications Among Chinese and South Asian Individuals in Ontario.

CJC open·2026
Same author

The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based Therapies.

CJC open·2022
Same author

Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study.

BMJ (Clinical research ed.)·2022
Same author

Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial.

Lancet (London, England)·2022
Same author

Low level of knowledge of heart attack symptoms and inappropriate anticipated treatment-seeking behaviour among older Chinese: a cross-sectional survey.

Journal of epidemiology and community health·2018

Related Experiment Video

Updated: Dec 21, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.2K

Heart failure with multiple comorbidities.

Gordon Moe1

  • 1St Michael's Hospital, University of Toronto, Toronto, Canada.

Current Opinion in Cardiology
|January 26, 2016
PubMed
Summary
This summary is machine-generated.

Heart failure patients often have comorbid conditions like lung disease, diabetes, and renal dysfunction, which worsen outcomes. Intravenous iron may benefit those with iron deficiency, but more research is needed on these complex cases.

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 17, 2014

25.0K

Related Experiment Videos

Last Updated: Dec 21, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.2K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 17, 2014

25.0K

Area of Science:

  • Cardiology
  • Pulmonology
  • Nephrology
  • Endocrinology

Background:

  • Heart failure (HF) management is complicated by numerous comorbid conditions.
  • These comorbidities significantly impact patient prognosis and treatment strategies.
  • Understanding the interplay between HF and coexisting diseases is crucial for effective care.

Purpose of the Study:

  • To review the latest developments in managing common comorbid conditions in heart failure patients.
  • To highlight the impact of chronic lung disease, diabetes, renal dysfunction, anemia, and iron deficiency on HF prognosis.

Main Methods:

  • This is a review article.
  • It synthesizes recent findings on the prevalence and impact of comorbidities in heart failure.
  • Focuses on heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).

Main Results:

  • Chronic lung disease is more prevalent and worsens prognosis in HFpEF compared to HFrEF.
  • Diabetes increases HF risk and adversely affects prognosis, though its impact on mortality and hospitalization is debated.
  • Renal dysfunction, anemia, and iron deficiency are common, with prognosis linked to long-term kidney function changes. Intravenous iron shows promise for iron-deficient patients.

Conclusions:

  • Comorbid conditions are prevalent in heart failure and significantly affect outcomes.
  • Intravenous iron infusion may benefit iron-deficient heart failure patients.
  • Future clinical trials must include patients with comorbidities and relevant endpoints.